AI Article Synopsis
- Virus-like particles (VLPs) derived from RNA bacteriophages are effective delivery systems for vaccine antigens that trigger strong immune responses.* -
- The text discusses recent advancements in using RNA phage VLPs to present various antigens through different display techniques, including genetic, enzymatic, and chemical methods.* -
- The focus is on how these VLPs can improve vaccine development by providing a more potent immune response.*
Article Abstract
Virus-like particles from a variety of RNA bacteriophages have turned out to be useful platforms for delivery of vaccine antigens in a highly immunogenic format. Here we update the current state of development of RNA phage VLPs as platforms for presentation of diverse antigens by genetic, enzymatic, and chemical display methods.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401894 | PMC |
| http://dx.doi.org/10.3390/ph14080764 | DOI Listing |
Publication Analysis
Top Keywords
rna phage
8
phage vlp-based
4
vlp-based vaccine
4
vaccine platforms
4
platforms virus-like
4
virus-like particles
4
particles variety
4
variety rna
4
rna bacteriophages
4
bacteriophages turned
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!